Skip to main content

Table 1 Clinical characteristics of studied subjects

From: Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

 

CKD (n = 16)

ESRD (n = 100)

Control (n = 100)

P value

Gender

 

0.004

Female

8 (50%)

31 (31%)

54 (54%)

Male

8 (50%)

69 (96%)

46 (46%)

 

Mean ± SD

Mean ± SD

Mean ± SD

Age

40.88 ± 11.10

47.10 ± 16.11

37.84 ± 12.73

< 0.001

HB conc.

16.04 ± 24.54

10.10 ± 1.96

12.31 ± 1.26

0.002

Creatinine conc.

3.69 ± 5.16

8.08 ± 3.03

0.82 ± 0.20

< 0.001

Bilirubin

0.47 ± 0.14

0.63 ± 0.20

0.40 ± 0.13

< 0.001

SGPT

30.0 ± 4.40

27.06 ± 21.85

21.06 ± 8.61

0.012

SGOT

38.63 ± 3.70

30.40 ± 21.19

29.38 ± 9.01

0.094

Ca

–

9.18 ± 0.80

8.27 ± 1.14

< 0.001

P

–

3.34 ± 0.58

5.98 ± 2.40

< 0.001

PTH

–

31.30 ± 11.3

477.54 ± 439.73

< 0.001

HBs Ag

Negative

16 (100.0%)

100 (100.0%)

0 (0.0%)

NA

HCV

Negative

16 (100%)

74 (74%)

100(100%)

< 0.001

 

Positive

0 (0%)

26 (26%)

0 (0%)

FBS

106.56 ± 43.58

125.5 ± 67.59

 

0.279

Urea

107.75 ± 30.36

   

GFR

28.75 ± 13.91

  Â